Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.27 USD | +0.40% | -0.32% | -28.51% |
03-27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
03-27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
Sales 2024 * | 357M 28.59B | Sales 2025 * | 403M 32.29B | Capitalization | 925M 74.08B |
---|---|---|---|---|---|
Net income 2024 * | 43M 3.44B | Net income 2025 * | 56M 4.48B | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
16.1
x | Employees | 895 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.76% |
Latest transcript on MiMedx Group, Inc.
1 day | +0.40% | ||
1 week | -0.32% | ||
Current month | -18.57% | ||
1 month | -17.61% | ||
3 months | -22.01% | ||
6 months | +1.95% | ||
Current year | -28.51% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 26/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 04/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 01/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 07/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 18/06/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.27 | +0.40% | 604,808 |
25/04/24 | 6.245 | -2.88% | 1,588,525 |
24/04/24 | 6.43 | -1.23% | 648,231 |
23/04/24 | 6.51 | +2.36% | 747,532 |
22/04/24 | 6.36 | +1.11% | 623,570 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.51% | 925M | |
-20.60% | 128M | |
-7.82% | 67.46M | |
+14.87% | 61.68M | |
+6.64% | 60.58M | |
+0.60% | 51.45M |
- Stock Market
- Equities
- MDXG Stock